Cancer Family
Malignant Genitourinary System Neoplasm
CI-CAN-00000233Explore in graph →
3,555 active trials61 approved drugs296 evidence items
- NCIt
- C156484
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000233Explore in graph →
Clinical trials
15,552 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (1,964)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT06867445 | Minimally Invasive Pelvic Exenteration in Vaginal or Cervical Cancer Recurrence(MIPEX) | recruiting | N/A | 64 | Fondazione Policlinico Universitario Agostino Gemelli IRCCSOTHER | 1 | Jul 17, 2025 | clinicaltrials |
| NCT06954233 | Voiding and Erectile Function After Retroperitoneal Lymph Node Dissection for Testicular Cancer(VEEF-RPLND-TC) | recruiting | — | 20 | Jagiellonian UniversityOTHER |
| 1 |
| Jul 16, 2025 |
| clinicaltrials |
| NCT07067255 | Sequential CD146 and GPC3 CAR-T Cell Therapy in Advanced Ovarian Cancer(BAH2573-104) | recruiting | Phase 1 / Phase 2 | 80 | Essen BiotechOTHER | 1 | Jul 16, 2025 | clinicaltrials |
| NCT07069335 | A Bioequivalence Study to Evaluate Pharmacokinetics and Safety of BR2022 and BR2022-1 in Patients With Deleterious or Suspected Deleterious Germline BRCA-Mutated Advanced Ovarian Cancer | recruiting | Phase 1 | 24 | Boryung Pharmaceutical Co., LtdINDUSTRY | 1 | Jul 16, 2025 | clinicaltrials |
| NCT05033301 | Evaluating the Effectiveness of the Nurse Ned Clinic(NurseNed) | recruiting | N/A | 600 | University Health Network, TorontoOTHER | 1 | Jul 11, 2025 | clinicaltrials |
| NCT06839144 | Inhibiting Beta-adrenergic and COX-2 Signaling During the Perioperative Period to Reduce Ovarian Cancer Progression(OC-POP-PT) | recruiting | Phase 2 | 60 | Tel-Aviv Sourasky Medical CenterOTHER_GOV | 1 | Jul 11, 2025 | clinicaltrials |
| NCT05427058 | Hypogastric Plexus Block and Ganglion Impar Block for Cervical and Endometrial Cancer Pain Management | recruiting | N/A | 36 | University of BrawijayaOTHER | 1 | Jul 10, 2025 | clinicaltrials |
| NCT05086692 | A Beta-only IL-2 ImmunoTherapY Study(ABILITY-1) | recruiting | Phase 1 / Phase 2 | 115 | Medicenna Therapeutics, Inc.INDUSTRY | 7 | Jul 9, 2025 | clinicaltrials |
| NCT06232083 | A Multi Tumor, Open Phase I Clinical Study on the Progression of First-line Anti-tumor Therapy Using Cardonizumab Combined With Pulsed Low-dose Rate External Irradiation (PLDR) | recruiting | Phase 1 | 20 | Anhui Provincial HospitalOTHER_GOV | 1 | Jul 9, 2025 | clinicaltrials |
| NCT07057375 | The Effect of Pulsed Electromagnetic Field Therapy on Muscle Mass and Muscle Strength in Prostate Cancer Patients Treated With Androgen Deprivation Therapy | recruiting | N/A | 110 | Chinese University of Hong KongOTHER | 1 | Jul 9, 2025 | clinicaltrials |
| NCT05582772 | TOward a comPrehensive Supportive Care Intervention for Older Men With Metastatic Prostate Cancer(TOPCOP3) | recruiting | N/A | 168 | University Health Network, TorontoOTHER | 1 | Jul 3, 2025 | clinicaltrials |
| NCT06776172 | Extended vs. No Pelvic Lymph Node Dissection During Radical Prostatectomy. DISSECTION 2.0. | recruiting | N/A | 400 | University Hospital, Basel, SwitzerlandOTHER | 1 | Jul 3, 2025 | clinicaltrials |
| NCT06903312 | Primary Tumor Ablation and Outcome in Metastatic Renal Cell Carcinoma Treated With Immunotherapy Combinations.(ITALIC-RCC) | recruiting | Phase 4 | 409 | Fondazione Policlinico Universitario Agostino Gemelli IRCCSOTHER | 1 | Jul 3, 2025 | clinicaltrials |
| NCT07051083 | Bladder Cancer Staging and Prediction of New Adjuvant Chemotherapy Efficacy Based on Deep Learning and Transfer Learning in Ultrasound-Magnetic Resonance-Pathology Multimodal Multiscale(MICS-BC) | recruiting | — | 480 | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityOTHER | 1 | Jul 3, 2025 | clinicaltrials |
| NCT03093688 | Clinical Safty and Efficacy Study of Infusion of iNKT Cells and CD8+T Cells in Patients With Advanced Solid Tumor | recruiting | Phase 1 / Phase 2 | 40 | Shanghai Public Health Clinical CenterOTHER_GOV | 1 | Jul 2, 2025 | clinicaltrials |
| NCT06392737 | Comparison of MRI Artificial Intelligence-guided cTB Versus Routine cTB in Prostate Cancer Diagnosis | recruiting | N/A | 360 | Peking University First HospitalOTHER | 1 | Jul 2, 2025 | clinicaltrials |
| NCT07022535 | Personalised Timing of Interval Debulking Surgery in Advanced Ovarian Cancer(PRESELECT-0) | recruiting | Phase 2 | 18 | The University of Hong KongOTHER | 1 | Jul 2, 2025 | clinicaltrials |
| NCT07023484 | Personalized Timing of Interval Debulking Surgery in Advanced Ovarian Cancer(Preselect-1) | recruiting | Phase 2 | 126 | The University of Hong KongOTHER | 2 | Jul 2, 2025 | clinicaltrials |
| NCT07047495 | Personalization of External Beam Radiation Therapy in Localised Tumours(MINIONS) | recruiting | — | 35 | European Institute of OncologyOTHER | 1 | Jul 2, 2025 | clinicaltrials |
| NCT07048327 | Cohort Study of Intrauterine Diseases(TJ Intrauterin) | recruiting | — | 2,000 | Wenwen WangOTHER | 1 | Jul 2, 2025 | clinicaltrials |
| NCT07039331 | Short-term Fasting Compared to Free Diet on Ovarian Cancer Patients(DIETA) | recruiting | N/A | 54 | Fondazione Policlinico Universitario Agostino Gemelli IRCCSOTHER | 1 | Jul 1, 2025 | clinicaltrials |
| NCT05796973 | Measuring Oncological Value of Exercise and Statin(MOVES) | recruiting | Phase 3 | 240 | Tampere University HospitalOTHER | 1 | Jun 27, 2025 | clinicaltrials |
| NCT06817174 | Ovarian Cancer Radiomics Approach in CT Led Evaluation(ORACLE) | recruiting | — | 168 | Imperial College Healthcare NHS TrustOTHER | 1 | Jun 27, 2025 | clinicaltrials |
| NCT07040657 | Comparison of Two-Position and Four-Position Cervical Injection Techniques for Sentinel Lymph Node Mapping in Endometrial Cancer Using Methylene Blue | recruiting | N/A | 100 | Dokuz Eylul UniversityOTHER | 1 | Jun 27, 2025 | clinicaltrials |
| NCT07034053 | Clofarabine Therapy in Locally Advanced or Metastatic Urothelial Carcinoma | recruiting | Phase 1 / Phase 2 | 50 | Ekaterina LaukhtinaOTHER | 1 | Jun 26, 2025 | clinicaltrials |
| NCT07038304 | The Impact of Metastatic Directed Radiotherapy (MDRT) on Oligoprogressive Castration Resistant Prostate Cancer (CRPC)(OLYMPIAN) | recruiting | Phase 2 | 35 | University Medical Center GroningenOTHER | 1 | Jun 26, 2025 | clinicaltrials |
| NCT04004312 | Single Fractions SBRT for Prostate Cancer | recruiting | N/A | 12 | Fabio CuryOTHER | 1 | Jun 25, 2025 | clinicaltrials |
| NCT04249154 | Postop Hypofractionated Radiation Therapy and LHRH in Patients With Prostate Cancer(PROMPT) | recruiting | Phase 2 | 77 | McGill University Health Centre/Research Institute of the McGill University Health CentreOTHER | 1 | Jun 25, 2025 | clinicaltrials |
| NCT06360653 | a SIngle Center Study of Post-operative STEReotactic RAdiotherapY for Endometrial Cancer(SISTER-RAY) | recruiting | N/A | 60 | ARNAS Civico Di Cristina Benfratelli HospitalOTHER | 1 | Jun 25, 2025 | clinicaltrials |
| NCT06769425 | HS-10502 Combination Treatment in Patients With Advanced Solid Tumors(HS-10502) | recruiting | Phase 1 | 157 | Jiangsu Hansoh Pharmaceutical Co., Ltd.INDUSTRY | 1 | Jun 24, 2025 | clinicaltrials |
| NCT06954584 | Fluzoparib+Bevacizumab/Dietary Intervention vs Fluzoparib Monotherapy as First-line Maintenance in HRD+/- Advanced Ovarian Cancer | recruiting | Phase 3 | 424 | Tongji HospitalOTHER | 1 | Jun 24, 2025 | clinicaltrials |
| NCT06379698 | Rein 3D PRINT PERSONALIZE(R3DP-P) | recruiting | N/A | 39 | University Hospital, BordeauxOTHER | 1 | Jun 22, 2025 | clinicaltrials |
| NCT05191680 | TherApeutics in Early ProState Cancer (TAPS02) | recruiting | Phase 2 | 90 | Cambridge University Hospitals NHS Foundation TrustOTHER | 1 | Jun 20, 2025 | clinicaltrials |
| NCT06626269 | Identification of Innovative Biomarkers Related to the Immune System or Tumor Microenvironment to Promote the Efficacy of Immunotherapies(HORIZON) | recruiting | N/A | 700 | Centre Hospitalier Universitaire de BesanconOTHER | 1 | Jun 20, 2025 | clinicaltrials |
| NCT06982469 | High Dose Rate (HDR) Brachytherapy Salvage After Prostatectomy | recruiting | — | 20 | Clinica Universidad de Navarra, Universidad de NavarraOTHER | 1 | Jun 19, 2025 | clinicaltrials |
| NCT02288676 | DOvEEgene/WISE Genomics: Diagnosing Ovarian and Endometrial Cancer Early Using Genomics(DOvEEgene) | recruiting | — | 1,200 | McGill UniversityOTHER | 1 | Jun 18, 2025 | clinicaltrials |
| NCT07003620 | Neoadjuvant Immunochemotherapy for Locally Advanced Cervical Cancer: a Prospective, Single-arm, Phase II Clinical Trial | recruiting | Phase 2 | 34 | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityOTHER | 1 | Jun 17, 2025 | clinicaltrials |
| NCT07025213 | Metabolic Effect of Exercise and Diet in Endometrial Cancer Patients Eligible for Staging Surgery. | recruiting | N/A | 80 | National Institute of CancerologíaOTHER_GOV | 1 | Jun 17, 2025 | clinicaltrials |
| NCT06621823 | Image-guided Ultrasound Robotic Intraoperative Evaluation of Lymph-nodes Status in Gynecological Malignancies(R-LYNUS) | recruiting | N/A | 160 | Fondazione Policlinico Universitario Agostino Gemelli IRCCSOTHER | 1 | Jun 15, 2025 | clinicaltrials |
| NCT06684652 | Evaluation of Targeted Biopsy Plus Sextant Biopsy in Diagnosis of Prostate Cancer | recruiting | N/A | 300 | Peking University First HospitalOTHER | 1 | Jun 13, 2025 | clinicaltrials |
| NCT07020169 | Using 3D Kidney Model Based on Artificial Intelligence to Assist Partial Nephrectomy: A Prospective Validation Study | recruiting | N/A | 232 | Shao PengfeiOTHER | 1 | Jun 13, 2025 | clinicaltrials |
| NCT06334809 | INSIDE: Identification of Genomic Screening Pathways in Cancer Patients With DNA Repair Alterations(INSIDE) | recruiting | — | 400 | Fondazione del Piemonte per l'OncologiaOTHER | 1 | Jun 12, 2025 | clinicaltrials |
| NCT06906705 | High-frequency Ultrasound for Intraoperative Lymph Node Assessment in Gynecological Cancer: From Surgery to Radiomics(RHINOCERUS) | recruiting | — | 160 | Fondazione Policlinico Universitario Agostino Gemelli IRCCSOTHER | 1 | Jun 12, 2025 | clinicaltrials |
| NCT04340024 | Discovery of Biomarkers for Intrinsic Radiation Sensitivity in Cancer Patients | recruiting | — | 5,000 | National Cancer Centre, SingaporeOTHER | 1 | Jun 11, 2025 | clinicaltrials |
| NCT06292286 | Secondary Interval Cytoreductive Surgery in Platinum-sensitive Recurrent Epithelial Ovarian Cancer(SCENIC) | recruiting | N/A | 18 | The University of Hong KongOTHER | 1 | Jun 11, 2025 | clinicaltrials |
| NCT06546267 | Advanced Radiotherapy (ART) in Prostate Cancer (PROST-ART)(PROST-ART) | recruiting | — | 2,500 | IRCCS San RaffaeleOTHER | 1 | Jun 11, 2025 | clinicaltrials |
| NCT05936736 | 24 Gy in One Fraction Urethral-sparing "HDR Like" SBRT for Prostate Cancer(PRO-FAST) | recruiting | N/A | 70 | IRCCS San RaffaeleOTHER | 1 | Jun 8, 2025 | clinicaltrials |
| NCT06215508 | Geriatric Assessment and Technology Evaluation in Prostate Cancer | recruiting | — | 120 | University of ChicagoOTHER | 1 | Jun 8, 2025 | clinicaltrials |
| NCT05326620 | National PROspective Infrastructure for Renal Cell Carcinoma (PRO-RCC)(PRO-RCC) | recruiting | — | 2,000 | PROspective Renal Cancer Cohort FoundationOTHER | 1 | Jun 6, 2025 | clinicaltrials |
| NCT05740956 | A Study of Hansoh (HS)-10502 in Patients With Advanced Solid Tumors | recruiting | Phase 1 | 318 | Jiangsu Hansoh Pharmaceutical Co., Ltd.INDUSTRY | 1 | Jun 5, 2025 | clinicaltrials |
Data updated 24 days agoSource updated Jul 17, 2025source: clinicaltrials